{"id":"ilomedin","rwe":[],"tags":[],"safety":{"boxedWarnings":[],"safetySignals":[],"drugInteractions":[],"commonSideEffects":[],"contraindications":["Bronchospasm","Chronic obstructive lung disease","Hepatic failure","Low blood pressure","Mild to Moderate Hypotension","Pulmonary edema"],"specialPopulations":{},"discontinuationRates":[],"seriousAdverseEvents":[]},"trials":[],"_chembl":null,"aliases":["Product Code 1-22460","ATC Code: B01AC11","concentrate and solvent for injection","Iloprost"],"patents":[],"pricing":[],"offLabel":[],"timeline":[],"_dailymed":null,"ecosystem":[],"mechanism":{"target":"Prostacyclin receptor, Prostaglandin D2 receptor, Prostaglandin E2 receptor EP1 subtype"},"_scrapedAt":"2026-03-28T03:35:24.806Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"references":[],"biosimilars":[],"competitors":[],"dataSources":[{"url":"https://drugcentral.org","name":"DrugCentral","fields":["indications","contraindications","safety","target","drugInteractions"],"retrievedDate":"2026-04-07"}],"indications":{"approved":[{"name":"Pulmonary arterial hypertension","diseaseId":"pulmonary-arterial-hypertension","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"}],"offLabel":[],"pipeline":[]},"labelChanges":[],"relatedDrugs":[],"trialDetails":[{"nctId":"NCT07450469","phase":"","title":"Field Study on Intravenous Iloprost for Treatment of Severe Frostbite at High Altitude","status":"NOT_YET_RECRUITING","sponsor":"Institute of Mountain Emergency Medicine","startDate":"2026-05","conditions":"Frostbite, Altitude, Field Physician Care","enrollment":10},{"nctId":"NCT06319274","phase":"PHASE2","title":"Infusion of Prostacyclin vs Placebo for 72-hours in Mechanically Ventilated Patients With Acute Respiratory Failure","status":"RECRUITING","sponsor":"Pär Johansson","startDate":"2024-04-15","conditions":"Acute Respiratory Failure, Endothelial Dysfunction, Pulmonary Infection","enrollment":450},{"nctId":"NCT04420741","phase":"PHASE2","title":"Infusion of Prostacyclin (Iloprost) vs Placebo for 72-hours in COVID-19 Patients With Respiratory Failure","status":"COMPLETED","sponsor":"Pär Johansson","startDate":"2020-06-15","conditions":"COVID-19, Respiratory Failure","enrollment":80},{"nctId":"NCT04543682","phase":"PHASE1, PHASE2","title":"A Clinical Trial Investigating Iloprost as Medication to Improve Bone Healing in Patients With Proximal Humeral Fracture","status":"UNKNOWN","sponsor":"Charite University, Berlin, Germany","startDate":"2022-05-12","conditions":"Proximal Humeral Fracture","enrollment":30},{"nctId":"NCT02685618","phase":"PHASE2","title":"Endothelial Dysfunction in Resuscitated Cardiac Arrest","status":"COMPLETED","sponsor":"Pär Johansson","startDate":"2016-02","conditions":"Cardiac Arrest","enrollment":50},{"nctId":"NCT02482402","phase":"PHASE2","title":"Iloprost for Bridging to Heart Transplantation in PH","status":"WITHDRAWN","sponsor":"Heidelberg University","startDate":"2015-02","conditions":"Chronic Left Ventricular Failure, Pulmonary Hypertension","enrollment":""},{"nctId":"NCT01774058","phase":"PHASE2","title":"The Arterial Measurement of the Blood Flow Volume After Iloprost Stimulation","status":"UNKNOWN","sponsor":"Prim PD Dr Afshin Assadian","startDate":"2012-10","conditions":"Diabetes, Arteriosclerosis, Peripheral Arterial Occlusive Disease","enrollment":100},{"nctId":"NCT02204852","phase":"PHASE2","title":"Co-administration of Iloprost and Eptifibatide in Septic Shock Patients","status":"COMPLETED","sponsor":"Sisse R. Ostrowski, MD PhD DMSc","startDate":"2014-09","conditions":"Septic Shock","enrollment":18},{"nctId":"NCT01532544","phase":"PHASE2","title":"Integrilin and Ilomedin in Combination in Comparison to Standard Treatment in Severe Pneumonia Patients With Severe Sepsis","status":"TERMINATED","sponsor":"Thrombologic ApS","startDate":"2012-06","conditions":"Pneumonia","enrollment":5},{"nctId":"NCT01458041","phase":"","title":"Iloprost Therapy in Patients With Critical Limb Ischemia","status":"COMPLETED","sponsor":"Bayer","startDate":"2011-08","conditions":"Peripheral Arterial Disease","enrollment":126},{"nctId":"NCT01549171","phase":"","title":"Enhanced Assisted Reproductive Technology Pregnancy Rate by Prostacyclin Analog (Iloprost)","status":"UNKNOWN","sponsor":"Fertility Specialists of Houston","startDate":"2010-01","conditions":"Pregnancy","enrollment":100},{"nctId":"NCT01179776","phase":"PHASE1, PHASE2","title":"Ilomedin Treatment for Patients Having Undergone Primary Percutaneous Coronary Intervention (PCI)","status":"COMPLETED","sponsor":"Thrombologic ApS","startDate":"2010-09","conditions":"Myocardial Infarct","enrollment":16},{"nctId":"NCT00622687","phase":"PHASE2","title":"Effect of Different Iloprost Doses on Symptoms in Systemic Sclerosis","status":"TERMINATED","sponsor":"Charite University, Berlin, Germany","startDate":"1997-09","conditions":"Systemic Sclerosis","enrollment":50}],"_emaApprovals":[],"_faersSignals":[],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"administration":{},"formularyStatus":[],"_approvalHistory":[],"developmentCodes":[],"ownershipHistory":[],"publicationCount":43,"therapeuticAreas":["Cardiovascular"],"biosimilarFilings":[],"companionDiagnostics":[],"genericManufacturerList":[],"phase":"phase_2","status":"active","brandName":"Ilomedin","genericName":"Ilomedin","companyName":"Prim PD Dr Afshin Assadian","companyId":"prim-pd-dr-afshin-assadian","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":4,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":false,"indications":true,"safety":false,"trials":true,"score":2}}